SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QLT PhotoTherapeutics (QLTI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Julian who wrote (971)7/31/2000 9:12:26 AM
From: Ian@SI  Read Replies (1) of 1321
 
Julian,

What do you say we split the difference.

I've got them for tomorrow, August 1st for reporting earnings.

And finally AHH recognized that QLT just might have some potential...

Adams, Harkness & Hill upgraded QLT Inc (QLTI) to an "Accumulate"
rating from "Market Performer," following the European Union's
approval of the company's Visudyne eye treatment.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News